mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |